Wang Jennifer J, Guillot Micael A, Bateman Simon D, Morris Kenneth R
Department of Industrial & Physical Pharmacy, Purdue University, 1336 Pharmacy Building, West Lafayette, IN 47907, USA.
J Pharm Sci. 2004 Feb;93(2):407-17. doi: 10.1002/jps.10553.
Adhesion problems are usually not identified until prolonged compression runs are studied near the end of the drug development process. During tablet manufacturing, adhesion problems encountered are usually addressed by statistically designed experiments based on experience. It would be a significant benefit for the pharmaceutical industry if adhesion problems could be identified early in drug development based on molecular considerations of the drug substance and/or prototype formulations. Drug substance-punch face interactions were reported in the first of the articles in this series, and focused on the elucidation of adhesion problems in tablet compression. It was hypothesized that the intermolecular interactions between drug molecules and the punch face was the first step (or criterion) in the adhesion process, and that the rank order of adhesion during tablet compression should correspond with the rank order of these energies of interaction. That is, the interaction between the molecular structure of the drug and the metal surface determines the primary interaction event or relative potential for adhesion, while the mechanical processes and/or lubrication effects may subsequently impact the extent of adhesion. Molecular simulations and atomic force microscopy were used to establish the rank order of the work of adhesion of a series of profen compounds. The results predicted that the relative degree of drug substance-punch face adhesion should decrease in the order of ketoprofen > ibuprofen > flurbiprofen. In this study, the authors investigated whether the rank order of the work of adhesion established on the molecular level and interparticulate level holds true in the tableting environment by measuring tablet take-off force, ejection force, and visual observation of the punch surfaces for both pure drug compacts and formulated tablets. The compaction simulator was used for pure profen compacts, while the instrumented tablet press for formulated tablets. Due to the inability to extract the adhesion force component from the total ejection force measurement, tablet ejection force was not used as a criterion to judge the adhesion behavior of the model compounds. The criteria used for judgement of punch face adhesion were tablet take-off force and visual observation of the punch faces. The rank order of adhesion for both pure drug and formulated tablets was determined to follow the order of ketoprofen > ibuprofen > flurbiprofen. The effect of run time on adhesion behavior was also investigated. Therefore, the rank order of the punch-face adhesion tendencies for the series of profen compounds was determined, and found to agree with the data from the predictive methods reported in the first article.
通常直到药物研发过程接近尾声,对长时间压缩过程进行研究时,才会发现黏附问题。在片剂生产过程中,遇到的黏附问题通常根据经验通过统计设计实验来解决。如果能在药物研发早期基于原料药和/或原型制剂的分子特性来识别黏附问题,将对制药行业大有裨益。本系列文章的第一篇报道了原料药与冲模表面的相互作用,重点阐述了片剂压制过程中的黏附问题。据推测,药物分子与冲模表面之间的分子间相互作用是黏附过程的第一步(或标准),并且片剂压制过程中的黏附等级顺序应与这些相互作用能的等级顺序相对应。也就是说,药物的分子结构与金属表面之间的相互作用决定了主要的相互作用事件或黏附的相对可能性,而机械过程和/或润滑作用可能随后影响黏附程度。分子模拟和原子力显微镜被用于确定一系列布洛芬类化合物的黏附功的等级顺序。结果预测,原料药与冲模表面的黏附相对程度应按酮洛芬>布洛芬>氟比洛芬的顺序降低。在本研究中,作者通过测量纯药物片剂和配方片剂的片剂脱模力、顶出力,并直观观察冲模表面,研究了在分子水平和颗粒间水平上确定的黏附功等级顺序在压片环境中是否成立。纯布洛芬类化合物片剂使用压实模拟器,而配方片剂使用装有仪器的压片机。由于无法从总顶出力测量中提取黏附力成分,片剂顶出力未被用作判断模型化合物黏附行为的标准。用于判断冲模表面黏附的标准是片剂脱模力和对冲模表面的直观观察。确定纯药物片剂和配方片剂的黏附等级顺序均遵循酮洛芬>布洛芬>氟比洛芬的顺序。还研究了运行时间对黏附行为的影响。因此,确定了该系列布洛芬类化合物冲模表面黏附倾向的等级顺序,发现与第一篇文章中报道的预测方法所得数据一致。